Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...
PregaTips on MSN
What to expect from this chronic inflammatory arthritis
Living with ankylosing spondylitis (AS) brings its own set of challenges, especially when you think about starting a family. You might notice changes in your symptoms, energy levels, or even how your ...
BHUBANESWAR: A 37-year-old man from Kendrapara district who had been suffering from ankylosing spondylitis (AS) for nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback